About pancyst

The mission of the Pancreatic Cyst and Cancer Early Detection Center (PCC-EDC) is to promote early detection and prevent pancreatic cancer through rigorous identification, tracking and treatment of patients “at risk” for pancreatic cancer through a multidisciplinary screening clinic, registry, community outreach, education and research discovery. There are at present 4 components to the PCC-EDC: IU Pancreatic Cyst (and Hereditary Pancreatic Cancer Screening) Clinic (IUPCC) IU Pancreas Cyst Registry (IUPCR) IU Pancreas Biomarker Discovery Lab (IUPBL) IU Pancreas Tissue-Fluid Bank (IUPTB)

Inaugural Andrea Gianaris Pancreatic Cancer Lectureship by Myles Brand Chair

Inaugural Andrea Gianaris Pancreatic Cancer Lectureship:
Murray Korc, M.D., Indiana University School of Medicine
Myles Brand Chair in Cancer Research (Pending Indiana University Board of Trustees approval)

Thursday, November 10, Joseph R. Walther Hall, 980 West Walnut Street, 2nd floor Auditorium, Indianapolis, IN 46202-5188
Lecture: 3:30 p.m.; Reception: 4:30 p.m.- RSVP to Meghan McFadden by November 8 (317) 274-7409
(800) 643-6975

Advertisements

Novel benign cyst biomarker may ease pancreatic cancer concern

Pancreatic Cyst and Cancer Early Detection Center: development of benign cyst marker at the IU School of Medicine and IU Simon Cancer Center by researchers C. Max Schmidt, MD, PhD, MBA and Michele Yip-Schneider, PhD may ease pancreatic cancer concern in select patients with pancreatic cysts. See below for WTHR Channel 13 link:
http://www.wthr.com/story/15508578/test-in-development-can-ease-cancer-concern

Website Launch

Patients, Families, Physicians and Scientists, enjoy this new resource.  We apologize for some parts of the website being under construction at site launch.  Future plans for the Pancreatic Cyst and Cancer Early Detection Center website are:

  1. Expansion of the network of pancreatic cyst and cancer early detection clinics, so patients may be well informed of where they may receive optimal treatment.
  2. Expansion of the resources section to include real time updates to current guidelines for surveillance of patients at increased risk of pancreatic cancer.

Please offer any suggestions on our Facebook, Twitter or send to pancyst@gmail.com

C. Max Schmidt, MD, PhD